Fumagillin and erythromycin in the treatment of amebiasis.
D000562:Amebiasis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003510:Cyclohexanes; D004404:Dysentery, Amebic / Q000628:therapy*; D004917:Erythromycin / Q000627:therapeutic use*; D005231:Fatty Acids, Unsaturated; D010272:Parasitic Diseases / Q000453:epidemiology*; D012717:Sesquiterpenes
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; D004917:Erythromycin; C026211:fumagillin
AMEBIASIS, INTESTINAL/therapy; ANTIBIOTICS/therapeutic use; ERYTHROMYCIN/therapeutic use; PARASITIC DISEASES/epidemiology